AU7902301A - Method for reducing exacerbations associated with copd - Google Patents

Method for reducing exacerbations associated with copd

Info

Publication number
AU7902301A
AU7902301A AU7902301A AU7902301A AU7902301A AU 7902301 A AU7902301 A AU 7902301A AU 7902301 A AU7902301 A AU 7902301A AU 7902301 A AU7902301 A AU 7902301A AU 7902301 A AU7902301 A AU 7902301A
Authority
AU
Australia
Prior art keywords
copd
exacerbations associated
reducing exacerbations
reducing
exacerbations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU7902301A
Other languages
English (en)
Inventor
Jeffrey D Edelson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU7902301A publication Critical patent/AU7902301A/xx
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU7902301A 2000-07-27 2001-07-26 Method for reducing exacerbations associated with copd Pending AU7902301A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22127500P 2000-07-27 2000-07-27
PCT/US2001/023542 WO2002009689A1 (en) 2000-07-27 2001-07-26 Method for reducing exacerbations associated with copd

Publications (1)

Publication Number Publication Date
AU7902301A true AU7902301A (en) 2002-02-13

Family

ID=22827112

Family Applications (2)

Application Number Title Priority Date Filing Date
AU7902301A Pending AU7902301A (en) 2000-07-27 2001-07-26 Method for reducing exacerbations associated with copd
AU2001279023A Ceased AU2001279023B2 (en) 2000-07-27 2001-07-26 Method for reducing exacerbations associated with COPD

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001279023A Ceased AU2001279023B2 (en) 2000-07-27 2001-07-26 Method for reducing exacerbations associated with COPD

Country Status (16)

Country Link
EP (1) EP1320361A4 (zh)
JP (1) JP2004505039A (zh)
KR (1) KR20030019620A (zh)
CN (1) CN1444476A (zh)
AR (1) AR029984A1 (zh)
AU (2) AU7902301A (zh)
BR (1) BR0112682A (zh)
CA (1) CA2417336A1 (zh)
CZ (1) CZ2003141A3 (zh)
HU (1) HUP0300685A3 (zh)
IL (1) IL153919A0 (zh)
MX (1) MXPA03000714A (zh)
NO (1) NO20030332D0 (zh)
PL (1) PL365612A1 (zh)
WO (1) WO2002009689A1 (zh)
ZA (1) ZA200300476B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
DE10110772A1 (de) * 2001-03-07 2002-09-12 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und PDE-IV-Inhibitoren
US7776315B2 (en) 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
GB0118373D0 (en) * 2001-07-27 2001-09-19 Glaxo Group Ltd Novel therapeutic method
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
DE10230769A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und PDE-IV-Inhibitoren
CA2503290C (en) 2003-03-10 2012-12-04 Altana Pharma Ag Novel process for the preparation of roflumilast
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
KR102087661B1 (ko) * 2018-07-27 2020-03-11 강원대학교산학협력단 Ｇｅｂｒ―７ｂ 화합물을 유효성분으로 포함하는 만성폐쇄성 폐질환의 예방 또는 치료용 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ3019A1 (fr) * 1999-03-01 2005-05-20 Smithkline Beecham Corp Utilisation d'un inhibiteur de pde4 dans la préparation d'un médicament contre la copd.
SE9902937D0 (sv) * 1999-08-18 1999-08-18 Astra Pharma Prod Pharmaceutical compositions
AU772909B2 (en) * 1999-10-29 2004-05-13 Smithkline Beecham Corporation Method for administering a phosphodiesterase 4 inhibitor

Also Published As

Publication number Publication date
BR0112682A (pt) 2003-06-24
WO2002009689A1 (en) 2002-02-07
AR029984A1 (es) 2003-07-23
AU2001279023B2 (en) 2005-11-10
ZA200300476B (en) 2004-04-23
CN1444476A (zh) 2003-09-24
NO20030332L (no) 2003-01-22
EP1320361A1 (en) 2003-06-25
MXPA03000714A (es) 2003-06-04
EP1320361A4 (en) 2006-04-05
IL153919A0 (en) 2003-07-31
JP2004505039A (ja) 2004-02-19
PL365612A1 (en) 2005-01-10
CA2417336A1 (en) 2002-02-07
CZ2003141A3 (cs) 2004-07-14
HUP0300685A3 (en) 2004-10-28
KR20030019620A (ko) 2003-03-06
NO20030332D0 (no) 2003-01-22
HUP0300685A2 (hu) 2003-12-29

Similar Documents

Publication Publication Date Title
GB0100001D0 (en) Components for roof assemblies
IL147075A0 (en) Clamp fitting for fastening glass panels
HUP0202651A3 (en) Method for producing l-phenylephrine hydrochloride
IL153919A0 (en) Method for reducing exacerbations associated with copd
IL134626A0 (en) Test structure for metal cmp process control
PL361146A1 (en) Method for producing isocyanato-organosilanes
IL144992A0 (en) Method for treating copd
HUP0102967A3 (en) Method for producing organosilylalkyl-polysulphanes
EP1245548A4 (en) PROCESS FOR THE MANUFACTURE OF VITROCERAMIC
EG23945A (en) Method for treating COPD
EP1440234A4 (en) METHOD AND MEANS FOR FUEL INJECTION
EP1365967A4 (en) RECEPTACLE FOR TRANSPORTING A BOTTLE
AU7265900A (en) Method for producing otoplastics
GB2377957B (en) Method for improving well quality
HU0105202D0 (en) Method for datatransmission
GB0019822D0 (en) Method and means for additional carriage space
AU2002255185A8 (en) Method for teaching fractions
TW448914U (en) Capping structure for vase
GB0027774D0 (en) Alignment method
HU9902898D0 (en) Method for influancing thermosensibility
GB0402085D0 (en) Method for improving well quality
HU0104169D0 (en) Process for plain-vine-stock wine-planting
TW487284U (en) Tool for fastening process
HUP0204192A3 (en) Method for producing n-alkoxy-n-alkylamides
AU1079002A (en) Method for making micromolds